参考文献/References:
[1] BAIDOUN F,ELSHIWY K,ELKERAIE Y,et al.Colorectal cancer epidemiology:Recent trends and impact on outcomes[J].Curr Drug Targets,2021,22(9):998-1009.
[2] YUE T,CHEN S,ZHU J,et al.The aging-related risk signature in colorectal cancer[J].Aging(Albany NY),2021,13(5):7330-7349.
[3] 徐军,白劼.同步放化疗治疗中晚期直肠癌疗效及对肿瘤细胞Bax、Ki-67表达的影响[J].陕西医学杂志,2021,50(5):587-589,602.
[4] DAVIDSON K W,BARRY M J,MANGIONE C M,et al.Screening for colorectal cancer:US preventive services task force recommendation statement[J].JAMA,2021,325(19):1965-1977.
[5] EBRAHIMZADEH S,AHANGARI H,SOLEIMANIAN A,et al.Colorectal cancer treatment using bacteria:Focus on molecular mechanisms[J].BMC Microbiol,2021,21(1):218.
[6] 阿地力江?阿力甫,卡哈尔?吐尔逊,克力比努尔?阿布力米提,等.环丙沙星联合茯苓皮汤加减治疗结直肠癌术后感染临床观察[J].西部中医药,2023,36(4):101-104.
[7] 章玲艳,吴会晨,汪飞,等.参苓白术散加减对结直肠癌患者化疗后骨髓抑制和免疫功能的影响[J].陕西中医,2023,44(8):1086-1089.
[8] 中华人民共和国卫生和计划生育委员会医政医管局,中华医学会肿瘤学分会.中国结直肠癌诊疗规范(2017年版)[J].中华外科杂志,2018,56(4):241-258.
[9] JONES G R,MOLLOY M P.Metformin,microbiome and protection against colorectal cancer[J].Dig Dis Sci,2021,66(5):1409-1414.
[10] PERROD G,RAHMI G,CELLIER C.Colorectal cancer screening in lynch syndrome:Indication,techniques and future perspectives[J].Dig Endosc,2021,33(4):520-528.
[11] WU Q,HUANG Q,JIANG Y,et al.Remodeling chondroitin-6-sulfate-mediated immune exclusion enhances anti-PD-1 response in colorectal cancer with microsatellite stability[J].Cancer Immunol Res,2022,10(2):182-199.
[12] 姚琳,杨帅.硬膜外阻滞联合全身麻醉对老年结直肠癌患者围术期免疫功能及胃肠功能影响的临床研究[J].陕西医学杂志,2022,51(4):449-453.
[13] 汤恒电,王炜.加味六君子汤治疗结直肠癌术后化疗不良反应的临床研究[J].广州中医药大学学报,2023,40(3):596-602.
[14] SUN X,NG T T H,SHAM K W Y,et al.Bufalin,a traditional Chinese medicine compound,prevents tumor formation in two murine models of colorectal cancer[J].Cancer Prev Res(Phila),2019,12(10):653-666.
[15] 李振前,杨梦春,刘戎惠,等.扶正消癌汤合四君子汤联合卡培他滨治疗晚期结直肠癌临床研究[J].陕西中医,2022,43(8):1037-1040.
[16] LIU N,WU C,JIA R,et al.Traditional Chinese medicine combined with chemotherapy and cetuximab or bevacizumab for metastatic colorectal cancer:A randomized,double-blind,placebo-controlled clinical trial[J].Front Pharmacol,2020,21(11):478.
[17] ZHAO H,HE M,ZHANG M,et al.Colorectal cancer,gut microbiota and traditional Chinese medicine:A systematic review[J].Am J Chin Med,2021,49(4):805-828.
[18] LU Y,ZHOU C,ZHU M,et al.Traditional Chinese medicine syndromes classification associates with tumor cell and microenvironment heterogeneity in colorectal cancer:A single cell RNA sequencing analysis[J].Chin Med,2021,16(1):133.
[19] LIU Y T,TZANG B S,YOW J,et al.Traditional Chinese medicine formula T33 inhibits the proliferation of human colorectal cancer cells by inducing autophagy[J].Environ Toxicol,2022,37(5):1007-1017.
[20] 陈益家,唐佳佳,刘世举.八珍散加减改善结直肠癌根治术后患者胃肠功能和免疫功能临床研究[J].陕西中医,2021,42(5):577-581.
[21] BUISMAN F E,FILIPE W F,GALJART B,et al.Adjuvant intra-arterial chemotherapy for patients with resected colorectal liver metastases:A systematic review and meta-analysis[J].HPB(Oxford),2022,24(3):299-308.
[22] RIESCO-MARTINEZ M C,MODREGO A,ESPINOSA-OLARTE P,et al.Perioperative chemotherapy for liver metastasis of colorectal cancer:Lessons learned and future perspectives[J].Curr Treat Options Oncol,2022,23(9):1320-1337.
[23] 王佳媚,杨同堂,孟云,等.健脾益气汤联合FOLFOX化疗治疗梗阻性结直肠癌临床研究[J].新中医,2023,55(2):119-122.
[24] 张远富.用益气健脾汤联合FOLFOX4化疗方案对手术后的结直肠癌患者进行治疗的效果分析[J].当代医药论丛,2022,20(4):169-171.
[25] 汪耔璇,李烜.补中益气汤联合化疗治疗晚期结直肠癌临床研究[J].陕西中医,2020,41(10):1414-1417.
相似文献/References:
[1]吴昭利,李成军,李仁廷,等.通麻汤联合穴位注射治疗结直肠癌奥沙利铂化疗相关外周神经毒性疗效研究*[J].陕西中医,2019,(9):1247.
WU Zhaoli,LI Chengjun,LI Renting,et al.Clinical study on Tongma decoction combined with acupoint injection in the treatment of peripheral neurotoxicity related to oxaliplatin chemotherapy for colorectal cancer[J].,2019,(4):1247.
[2]林增海,陆 军,王凯松.槲皮素对5-FU诱导的结直肠癌SW480细胞耐药及自噬调控机制研究[J].陕西中医,2021,(10):1338.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.004]
LIN Zenghai,LU Jun,WANG Kaisong.Regulatory mechanism of quercetin on resistance and autophagy of 5-FU induced colorectal cancer SW480 cells[J].,2021,(4):1338.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.004]
[3]郑佳露,郑金洲,顾 贤.藤龙补中汤联合化疗治疗晚期结直肠癌疗效研究[J].陕西中医,2023,(8):1042.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.010]
ZHENG Jialu,ZHENG Jinzhou,GU Xian.Observation on the therapeutic effect of Tenglong Buzhong decoction combined with chemotherapy on advanced colorectal cancer[J].,2023,(4):1042.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.010]
[4]章玲艳,吴会晨,汪 飞,等.参苓白术散加减对结直肠癌患者化疗后骨髓抑制和免疫功能的影响[J].陕西中医,2023,(8):1086.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.020]
ZHANG Lingyan,WU Huichen,WANG Fei,et al.Effects of modified Shenling Baizhu powder on bone marrow suppression and immune function in patients with colorectal cancer after chemotherapy[J].,2023,(4):1086.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.020]
[5]塔吉姑丽·吐逊,陈治宇,马琪琪,等.白头翁汤联合PD-1抑制剂对结肠癌小鼠免疫微环境的影响[J].陕西中医,2025,46(2):170.[doi:DOI:10.3969/j.issn.1000-7369.2025.02.005]
TAJIGULI Tuxun,CHEN Zhiyu,MA Qiqi,et al.Effect of Baitouweng decoction combined with PD-1 inhibitor on immune micro-environment of colon cancer mice[J].,2025,46(4):170.[doi:DOI:10.3969/j.issn.1000-7369.2025.02.005]
[6]宁永波,罗珍莲,宋子豪,等.基于“亢火害物”探讨结直肠“炎-癌转化”及防治思路[J].陕西中医,2025,46(4):512.[doi:DOI:10.3969/j.issn.1000-7369.2025.04.017]
NING Yongbo,LUO Zhenlian,SONG Zihao,et al.The prevention and treatment of colorectal “inflammation cancer transformation” based on “raging inferno and injuring wu”[J].,2025,46(4):512.[doi:DOI:10.3969/j.issn.1000-7369.2025.04.017]